ANEB
Anebulo Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website anebulo.com
- Employees(FY) 2
- ISIN US0345691036
Performance
-7.66%
1W
-25.45%
1M
-26.26%
3M
-4.65%
6M
-15.29%
YTD
-9.29%
1Y
Profile
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.
Technical Analysis of ANEB 2024-05-31
Overview:
In analyzing the technical indicators for ANEB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2022-09-19 20:00
- 2022-09-08 20:00
- 2022-08-23 05:00
- 2022-08-16 03:00
Sidoti's August Micro-Cap Virtual Conference(Yahoo Finance)
- 2022-07-13 18:23
- 2022-07-04 19:57
- 2022-07-04 18:00
- 2022-06-23 04:00
- 2022-05-24 04:00
- 2022-05-10 21:00
- 2022-03-31 19:00
- 2022-02-10 19:00
- 2022-02-03 15:30
- 2022-01-05 18:00
- 2022-01-05 18:00
- 2022-01-03 18:00
- 2022-01-02 18:00
- 2021-11-11 19:00
- 2021-10-12 20:00
- 2021-10-11 20:59
- 2021-10-04 20:00
- 2021-09-26 19:41
- 2021-09-22 04:05
- 2021-09-19 20:13
- 2021-09-12 20:00
- 2021-09-12 20:00
- 2021-09-06 20:00
- 2021-09-06 19:04
Anebulo is Developing an Antidote to Cannabis Intoxication(Yahoo Finance)
- 2021-08-22 20:31
- 2021-08-15 20:39
Alcohol, Cannabis and Synergistic Risk(Yahoo Finance)